Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jie Zang

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
Clinical Nuclear Medicine|April 16, 2019
Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor LesionsJingnan Wang, Jie Zang, Hao Wang, et al.
Journal of Nanobiotechnology|December 28, 2022
Acidic and hypoxic tumor microenvironment regulation by CaO<sub>2</sub>-loaded polydopamine nanoparticlesShuangrong Ruan, Weimin Yin, Jiao Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 23, 2020
Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of <sup>177</sup>Lu-DOTA-EB-TATEQingxing Liu, Jie Zang, Huimin Sui, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2024
Diagnostic Performance of [<sup>18</sup>F]AlF-Thretide PET/CT in Patients with Newly Diagnosed Prostate Cancer Using Histopathology as Reference StandardJie Zang, Yun Yang, Shaoming Chen, et al.
Journal of Nanobiotechnology|November 23, 2023
Pathologically catalyzed physical coating restores the intestinal barrier for inflammatory bowel disease therapyYuge Zhao, Ruiqing He, Jie Zang, et al.
Advanced Healthcare Materials|November 17, 2023
NOX2 Enzyme Mimicking Nano-Networks Regulate Tumor-Associated Macrophages to Initiate Both Innate and Adaptive Immune EffectsTingting Zhang, Weimin Yin, Yuge Zhao, et al.
Journal of Medicinal Chemistry|March 23, 2019
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological MalignanciesXuewu Liang, Jie Zang, Xiaoyang Li, et al.
British Journal of Cancer|May 31, 2022
HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3Wei-Jie Zang, Yi-Lin Hu, Chen-Yu Qian, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2025
First-in-human study of a novel bifunctional PET tracer [<sup>68</sup>Ga]Ga-DOTA-NI-FAPI-04 targeting FAP and hypoxiaJie Zang, Hongfei Cheng, Yang Luo, et al.
Current Medical Science|December 22, 2022
Increased Prevalence of Thyroid Nodules Across Nearly 10 Years in Shanghai, ChinaMeng-Ying Qu, Wei Tang, Xue-Ying Cui, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Clinical Nuclear Medicine|April 16, 2019
Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor LesionsJingnan Wang, Jie Zang, Hao Wang, et al.
Journal of Nanobiotechnology|December 28, 2022
Acidic and hypoxic tumor microenvironment regulation by CaO<sub>2</sub>-loaded polydopamine nanoparticlesShuangrong Ruan, Weimin Yin, Jiao Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 23, 2020
Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of <sup>177</sup>Lu-DOTA-EB-TATEQingxing Liu, Jie Zang, Huimin Sui, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2024
Diagnostic Performance of [<sup>18</sup>F]AlF-Thretide PET/CT in Patients with Newly Diagnosed Prostate Cancer Using Histopathology as Reference StandardJie Zang, Yun Yang, Shaoming Chen, et al.
Journal of Nanobiotechnology|November 23, 2023
Pathologically catalyzed physical coating restores the intestinal barrier for inflammatory bowel disease therapyYuge Zhao, Ruiqing He, Jie Zang, et al.
Advanced Healthcare Materials|November 17, 2023
NOX2 Enzyme Mimicking Nano-Networks Regulate Tumor-Associated Macrophages to Initiate Both Innate and Adaptive Immune EffectsTingting Zhang, Weimin Yin, Yuge Zhao, et al.
Journal of Medicinal Chemistry|March 23, 2019
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological MalignanciesXuewu Liang, Jie Zang, Xiaoyang Li, et al.
British Journal of Cancer|May 31, 2022
HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3Wei-Jie Zang, Yi-Lin Hu, Chen-Yu Qian, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2025
First-in-human study of a novel bifunctional PET tracer [<sup>68</sup>Ga]Ga-DOTA-NI-FAPI-04 targeting FAP and hypoxiaJie Zang, Hongfei Cheng, Yang Luo, et al.
Current Medical Science|December 22, 2022
Increased Prevalence of Thyroid Nodules Across Nearly 10 Years in Shanghai, ChinaMeng-Ying Qu, Wei Tang, Xue-Ying Cui, et al.
Pageof 19